Sort
30,917 grants matching “tumor microenvironment”
Genetic Mechanisms Controlling Kidney Cancer Immune Escape
$424,094Haydn Kissick · Emory University · R01 · FY2024 · CA
Macrophage-based ovarian cancer immunotherapy
$424,055Fiona E Yull · Vanderbilt University · R01 · FY2021 · CA
Tubulin microtentacles in detached mammary epithelial cells
$424,018Stuart S Martin · University Of Maryland Baltimore · R01 · FY2023 · CA
Tubulin microtentacles in detached mammary epithelial cells
$424,018Stuart S Martin · University Of Maryland Baltimore · R01 · FY2025 · CA
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
$424,015Weizhou Zhang · University Of Florida · R01 · FY2024 · CA
Surgical and Animal Core
$424,010Dai Fukumura · Massachusetts General Hospital · P01 · FY2013 · CA
(PQ5) Microenvironmental Regulation of Mitochondrial Heterogeneity in Cancer Metastasis
$423,962Keyue Shen · University Of Southern California · R01 · FY2023 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$423,960Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · CA
Anti-Sox2 immunotherapy to prevent multiple myeloma relapse
$423,948Alfred L. Garfall · University Of Pennsylvania · R21 · FY2020 · CA
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems
$423,892Manish Aghi · University Of California, San Francisco · R01 · FY2020 · CA
Chimeric Anti-Fibulin-3 Reagents For Targeted Therapy Of Glioblastoma
$423,853Mariano Sebastian Viapiano · Brigham And Women'S Hospital · R21 · FY2015 · NS
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$423,829Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$423,760Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2024 · CA
Decoding the molecular basis of cellular identity in adult malignant gliomas
$423,754Michael Clark Oldham · University Of California, San Francisco · R01 · FY2022 · CA
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2022 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2019 · OD
Mechanosensing Via Cytoskeletal Strain
$423,750Gregory M Alushin · Rockefeller University · DP5 · FY2018 · OD
Mechanosensing Via Cytoskeletal Strain
$423,750Gregory M Alushin · Rockefeller University · DP5 · FY2016 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2020 · OD
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
$423,750Julie Magarian Blander · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AI
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Mechanosensing Via Cytoskeletal Strain
$423,750Gregory M Alushin · Rockefeller University · DP5 · FY2019 · OD